Long-term antidepressant use and the risk of type 2 diabetes mellitus: A population-based, nested case-control study in Taiwan

Journal of Clinical Psychiatry

Volumn 75, Issue 1, 2014, Pages 31-38

  Wu, Chi Shin ^a,b,c   Gau, Susan Shur Fen ^b,c   Lai, Mei Shu ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b Institute of Occupational Medicine and Industrial Hygiene   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MELITRACEN; MILNACIPRAN; MIRTAZAPINE; PAROXETINE; SEROTONIN ANTAGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROPENSITY SCORE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SENSITIVITY ANALYSIS; TAIWAN; TREATMENT DURATION; WEIGHT GAIN; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; MIDDLE AGED; ODDS RATIO; REGISTRIES; RISK; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; TAIWAN; TIME FACTORS; YOUNG ADULT;

EID: 84893153984     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08421     Document Type: Article

References (46)

1. van Dieren S, Beulens JW, van der Schouw YT, et al. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17(suppl 1):S3-S8. doi:10.1097/01.hjr.0368191.8614.5a PubMed
2. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053. doi:10.237/diacare.27.5.1047 PubMed
3. Chang CH, Shau WY, Jiang YD, et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med. 2010;27(6):636-643. doi:10.1/j.1464-5491.2010.0307.x PubMed
4. Mezuk B, Eaton WW, Albrecht S, et al. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383-2390. doi:10.237/dc08-0985 PubMed
5. Knol MJ, Twisk JW, Beekman AT, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus: a meta-analysis. Diabetologia. 2006;49(5):837-845. doi:10.107/s0125-06-0159-x PubMed
6. Chen PC, Chan YT, Chen HF, et al. Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression. Diabetes Care. 2013;36(2):376-382. doi:10.237/dc12-0473 PubMed
7. Fava M. Weight gain and antidepressants. J Clin Psychiatry. 2000;61(suppl 11):37-41. PubMed
8. Raeder MB, Bjelland I, Emil Vollset S, et al. Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study. J Clin Psychiatry. 2006;67(12):1974-1982. doi:10.408/JCP.v67n1219 PubMed
9. Khoza S, Barner JC. Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reports. Int J Clin Pharmacol. 2011;33(3):484-492. doi:10.107/s11096-01-9507-0 PubMed
10. Andersohn F, Schade R, Suissa S, et al. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry. 2009;166(5):591-598. doi:10.176/api.ajp.208.08071065 PubMed
11. Atlantis E, Browning C, Sims J, et al. Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA). Int J Geriatr Psychiatry. 2010;25(7):688-696. doi:10.102/gps.2409 PubMed
12. Campayo A, de Jonge P, Roy JF, et al; ZARADEMP Project. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. Am J Psychiatry. 2010;167(5):580-588. doi:10.176/api.ajp.209.0901038 PubMed
13. Derijks HJ, Meyboom RHB, Heerdink ER, et al. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol. 2008;64(5):531-538. doi:10.107/s028-07-041-y PubMed
14. Kivimäki M, Batty GD, Jokela M, et al. Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association? Biol Psychiatry. 2011;70(10):978-984. doi:10.1016/j.biopsych.201.07.08 PubMed
15. Kivimäki M, Hamer M, Batty GD, et al. Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study. Diabetes Care. 2010;33(12):2611-2616. doi:10.237/dc10-187 PubMed
16. Knol MJ, Geerlings MI, Egberts ACG, et al. No increased incidence of diabetes in antidepressant users. Int Clin Psychopharmacol. 2007;22(6):382-386. doi:10.1097/YIC.0b013e328202c0e PubMed
17. Ma Y, Balasubramanian R, Pagoto SL, et al. Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women. Diabetes Care. 2011;34(11):2390-2392. doi:10.237/dc1-123 PubMed
18. Pan A, Sun Q, Okereke OI, et al. Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia. 2012;55(1):63-72. doi:10.107/s0125-01-268-4 PubMed
19. Rubin RR, Ma Y, Marrero DG, et al; Diabetes Prevention Program Research Group. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care. 2008;31(3):420-426. doi:10.237/dc07-1827 PubMed
20. Wilkins TL, Sambamoorthi U. Antidepressant use, depression, lifestyle factors, and new-onset diabetes. Int Clin Psychopharmacol. 2011;26(3):159-168. doi:10.1097/YIC.0b013e328342ce31 PubMed
21. Lustman PJ, Freedland KE, Griffith LS, et al. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000;23(5):618-623. doi:10.237/diacare.23.5.618 PubMed
22. Khoza S, Barner JC, Bohman TM, et al. Use of antidepressant agents and the risk of type 2 diabetes. Eur J Clin Pharmacol. 2012;68(9):1295-1302. doi:10.107/s0228-01-168-3 PubMed
23. Kivimäki M, Tabák AG, Lawlor DA, et al. Antidepressant use before and after the diagnosis of type 2 diabetes: a longitudinal modeling study. Diabetes Care. 2010;33(7):1471-1476. doi:10.237/dc09-2359 PubMed
24. Knol MJ, Heerdink ER, Egberts ACG, et al. Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med. 2007;69(4):300-305. doi:10.1097/PSY.0b013e31805f48b9 PubMed
25. Horwitz RI, Feinstein AR. The problem of "protopathic bias" in case-control studies. Am J Med. 1980;68(2):255-258. doi:10.1016/02-9343(80) 90363-0 PubMed
26. Rothman KJ. Induction and latent periods. Am J Epidemiol. 1981;114(2):253-259. PubMed
27. Tamim H, Monfared AA, LeLorier J. Application of lag-time into exposure definitions to control for protopathic bias. Pharmacoepidemiol Drug Saf. 2007;16(3):250-258. doi:10.102/pds.1360 PubMed
28. The National Health Insurance Research Database. http://nhird.nhri.org. tw/ en/index.htm. Accessed October 31, 2013.
29. Tai YM, Gau SS, Gau CS. Injury-proneness of youth with attention-deficit hyperactivity disorder: a national clinical data analysis in Taiwan. Res Dev Disabil. 2013;34(3):1100-1108. doi:10.1016/j.rid.2012.1.027 PubMed
30. Lin CC, Lai MS, Syu CY, et al. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc. 2005;104(3):157-163. PubMed
31. WHO Collaborating Centre for Drug Statistic Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: WHO; 2009.
32. Brown LC, Majumdar SR, Newman SC, et al. History of depression increases risk of type 2 diabetes in younger adults. Diabetes Care. 2005;28(5):1063-1067. doi:10.237/diacare.28.5.1063 PubMed
33. Brown LC, Majumdar SR, Johnson JA. Type of antidepressant therapy and risk of type 2 diabetes in people with depression. Diabetes Res Clin Pract. 2008;79(1):61-67. doi:10.1016/j.diabres.207.07.09 PubMed
34. Weisler RH, Johnston JA, Lineberry CG, et al. Comparison of bupropion and trazodone for the treatment of major depression. J Clin Psychopharmacol. 1994;14(3):170-179. doi:10.1097/04714-194060-04 PubMed
35. Wu CS, Shau WY, Chan HY, et al. Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009. Pharmacoepidemiol Drug Saf. 2012;21(9):980-988. doi:10.102/pds.325 PubMed
36. Harvey BH, Bouwer CD. Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors. Clin Neuropharmacol. 2000;23(2):90-97. doi:10.1097/02826-2030-06 PubMed
37. Levkovitz Y, Ben-Shushan G, Hershkovitz A, et al. Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases. Mol Cell Neurosci. 2007;36(3):305-312. doi:10.1016/j.mcn
38. Yamada J, Sugimoto Y, Inoue K. Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms. Eur J Pharmacol. 1999;382(3):211-215. doi:10.1016/S014-29(9)0593-2 PubMed
39. Van Oekelen D, Luyten WH, Leysen JE. 5-HT2A and 5-HT2C receptors and their atypical regulation properties. Life Sci. 2003;72(22):2429-2449. doi:10.1016/S024-3205(03)0141-3 PubMed
40. Gilles M, Wilke A, Kopf D, et al. Antagonism of the serotonin (5-HT)-2 receptor and insulin sensitivity: implications for atypical antipsychotics. Psychosom Med. 2005;67(5):748-751. doi:10.1097/01.psy.017494.91245.34 PubMed
41. Liao SC, Chen WJ, Lee MB, et al. Low prevalence of major depressive disorder in Taiwanese adults: possible explanations and implications. Psychol Med. 2012;42(6):1227-1237. doi:10.1017/S032917102364 PubMed
42. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220-229. doi:10.101/archgenpsychiatry.2010.2 PubMed
43. Chang HH, Yen ST. Association between obesity and depression: evidence from a longitudinal sample of the elderly in Taiwan. Aging Ment Health. 2012;16(2):173-180. doi:10.1080/13607863.201.605053 PubMed
44. Kuo SY, Lin KM, Chen CY, et al. Depression trajectories and obesity among the elderly in Taiwan. Psychol Med. 2011;41(8):1665-1676. doi:10.1017/ S032917102473 PubMed
45. Wen CP, Tsai SP, Chung WS. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med. 2008;148(4):258-267. doi:10.7326/03-4819-148-4-20802190-004 PubMed
46. McBean AM, Li S, Gilbertson DT, et al. Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, Hispanics, and Asians. Diabetes Care. 2004;27(10):2317-2324. doi:10.237/diacare.27.10.2317 PubMed